Kezar Life Sciences halts mid-stage trial for lupus treatment

Kezar Life Sciences

30/09/2024 13:42

Sept 30 (Reuters) - Kezar Life Sciences  KZR.O  said on
Monday it was stopping enrollment of new patients and dosing of
ongoing patients in its mid-stage study for treating a symptom
of lupus, following the recommendation of an independent
committee after four deaths.

 (Reporting by Sneha S K in Bengaluru)
 ((Sneha.SK@thomsonreuters.com))